Variant report
Variant | esv3349182 |
---|---|
Chromosome Location | chr7:13510761-13535910 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:13486434..13489093-chr7:13519344..13521855,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560603066 | chr7:13512011-13512012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143078426 | chr7:13512018-13512019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2723453 | chr7:13512089-13512090 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs73261143 | chr7:13512108-13512109 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs371517785 | chr7:13512123-13512124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531794559 | chr7:13512142-13512143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547950582 | chr7:13512171-13512172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568165453 | chr7:13512180-13512181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533531367 | chr7:13512188-13512189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4719367 | chr7:13512193-13512194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553222367 | chr7:13512211-13512212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550234737 | chr7:13512247-13512248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77355207 | chr7:13512252-13512253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570644171 | chr7:13512298-13512299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539703434 | chr7:13512308-13512309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146163400 | chr7:13512346-13512347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576275941 | chr7:13512363-13512364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs57780365 | chr7:13512368-13512369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10235896 | chr7:13512370-13512371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201060734 | chr7:13512371-13512372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78197047 | chr7:13512381-13512382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2723452 | chr7:13512600-13512601 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs375127440 | chr7:13512609-13512610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555788602 | chr7:13512628-13512629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566223897 | chr7:13512702-13512703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113240315 | chr7:13512722-13512723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184607101 | chr7:13512731-13512732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10265877 | chr7:13512776-13512777 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs199963833 | chr7:13512820-13512821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201068965 | chr7:13512826-13512827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201072715 | chr7:13512827-13512828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113717567 | chr7:13512828-13512829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561622820 | chr7:13512860-13512861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527419044 | chr7:13512862-13512863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2723451 | chr7:13512864-13512865 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs142395695 | chr7:13512874-13512875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189075089 | chr7:13512875-13512876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73261147 | chr7:13512879-13512880 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs569999012 | chr7:13512958-13512959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74721945 | chr7:13512963-13512964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555585073 | chr7:13513068-13513069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7777457 | chr7:13513102-13513103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534259022 | chr7:13513155-13513156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150525202 | chr7:13513183-13513184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs117071603 | chr7:13513236-13513237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545811230 | chr7:13513258-13513259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13233056 | chr7:13513262-13513263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139516816 | chr7:13513271-13513272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116900003 | chr7:13513282-13513283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559351106 | chr7:13513323-13513324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:13512000-13512400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr7:13512600-13513600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:13516000-13516400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr7:13529000-13529600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr7:13535800-13537400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |